Mecklenburg Medical Group

Charlotte, North Carolina 28211

0 studies enrolling now · 4 studies all time

What they study most

Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Hypoparathyroidism, Multiple Myeloma

Studies at this site

• A Registry for Participants With Chronic Hypoparathyroidism — Completed
• Trial of Romidepsin and Bortezomib for Multiple Myeloma — Stopped early
• Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML — Completed
• A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I) — Completed